Latest Commercialization News

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Toubani Resources has raised A$29 million through a strategic placement led by A2MP Investments, which also commits to a US$160 million debt facility, positioning the Kobada Gold Project for a final investment decision by late 2025.

Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.

Medallion Metals has advanced negotiations to acquire the Cosmic Boy Process Plant at Forrestania, while delivering robust drilling results at Ravensthorpe and securing a $6.5 million placement to fund its sulphide development strategy.

Adriatic Metals delivered a strong Q1 2025 with a 46% jump in silver equivalent production and a 26% rise in sales, setting the stage for commercial production in Q2. Key infrastructure milestones and debt repayments underpin confidence in the company’s growth trajectory.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Impact Minerals reports significant progress across multiple fronts, including a major nickel-copper-PGM anomaly at Arkun and nearing completion of the Lake Hope High Purity Alumina pre-feasibility study.

PEXA has achieved a crucial regulatory milestone with FCA approval to operate as an Authorised Payment Institution in the UK, paving the way for its Sale & Purchase product launch later this year.

Terra Metals has made significant strides at its Dante polymetallic project, producing three high-grade concentrates and extending mineralisation, while securing a strategic tenement option to expand its resource base.

INOVIQ Limited reports significant progress in its exosome-based cancer diagnostics and therapeutics, including expanded customer adoption, advanced AI screening tests, and strategic partnerships with leading research centres.

Helios Energy has confirmed significant contingent resources at its Presidio Project in West Texas, supported by new technical partnerships and a strengthened leadership team. The company raised $4.3 million to advance its development plans amid a shifting US energy landscape.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.